Bristol-Myers Squibb
BMY
BMY
2,437 hedge funds and large institutions have $88.5B invested in Bristol-Myers Squibb in 2025 Q4 according to their latest regulatory filings, with 365 funds opening new positions, 869 increasing their positions, 954 reducing their positions, and 141 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2.71% more ownership
Funds ownership: 77.91% → 80.62% (+2.7%)
9% less repeat investments, than reductions
Existing positions increased: 869 | Existing positions reduced: 954
30% less call options, than puts
Call options by funds: $1.33B | Put options by funds: $1.91B
Holders
2,437
Holding in Top 10
30
Calls
$1.33B
Puts
$1.91B
Top Buyers
| 1 | +$786M | |
| 2 | +$448M | |
| 3 | +$377M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$293M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$199M |
Top Sellers
| 1 | -$548M | |
| 2 | -$520M | |
| 3 | -$492M | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$273M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$217M |
